Hooker expects Inovalon's revenue to come in at $637 million in 2019, above the analyst forecasts for $633 million. Cost of Revenue will likely drop to about 165.9 M in 2020. 5 Nov 2019, 09:01 @newswire Frost ... Inovalon Expects Fourth Quarter Revenue Growth of 18% to 20% and Adjusted EBITDA Growth of 78% Assuming the Midpoint, Consistent with Prior Guidance. Specifically, in Q3 2020's revenue was $161.4M; in Q2 2020, it was $162.2M; in Q1 2020, it was $154.2M; in Q4 2019, Inovalon's revenue was $173.5M. Revenue; Computer and Technology: Information Technology Services: $3.049B: $0.642B: Inovalon Holdings, Inc. is a technology company which provides cloud-based data analytics and data-driven intervention platforms for healthcare sector. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Inovalon Holdings's revenue for the three months ended in Mar. TTM subscription-based platform revenue for the third quarter of 2020 was $565.1 million, a period-over-period increase of 13%, compared with $498.3 million for the third quarter 2019 TTM period. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Find revenue, contact, ... Why Inovalon Health just acquired a Minnesota health company for $1.2 billion. Company Issues Preliminary Fourth Quarter and Full Year 2017 Expectations Inovalon Holdings, Inc. (INOV) FORM 10-Q | Quarterly Report. Largest Public Companies in Greater D.C. The company operates through IT and services group. Revenue for the second quarter of 2020 was $162.2 million, a year-over-year increase of 3% compared with $157.0 million for the second quarter of 2019. Annual Report 2019 Form 10-K (NASDAQ:INOV) Published: February 20th, 2019 PDF generated by stocklight.com . Inovalon Holdings, which belongs to the Zacks Computers - IT Services industry, posted revenues of $166.45 million for the quarter ended September 2019, surpassing the Zacks Consensus Estimate by 1.02%. This compares to year-ago revenues of $145.81 million. The top 10 competitors average 13.6B. Inovalon market cap is $3.8 b, and annual revenue was $642.41 m in FY 2019. )* Inovalon Holdings, Inc. (Name of Issuer) Common Class A (Title of Class of Securities) 45781D101 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box … TTM revenue for the first quarter of 2020 was $651.1 million, a period-over-period increase of 12% compared with $580.4 million for the first quarter 2019 TTM period. 2019-02-13 sec.gov - UNITED STATES* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. Driven by the first waves of disease-burden based reimbursement models and quality incentive programs, data has gained an increasing role in U.S. healthcare. Over the last four quarters, Inovalon's revenue has decreased by 7%. revenue management from ABILITY Silicon Valley, CA and Minneapolis – (December 18, 2019) – PracticeSuite, a Silicon Valley, California-based SaaS physician Pract ice Management Software platform and Revenue Cycle services company, and ABILITY Network, an Inovalon company (Nasdaq: INOV) providing advan ced, Inovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Second-quarter 2019 revenue was $157 million, an increase of 3% year over year and 8% sequentially. Inovalon Holdings (INOV) delivered earnings and revenue surprises of -44.44% and -7.05%, respectively, for the quarter ended December 2018. Inovalon Holdings reported Consolidated Income of 7.78 Million in 2019. Revenue for the first quarter of 2020 was $154.2 million, a year-over-year increase of 6.0% compared with $145.5 million for the first quarter of 2019. Interest Expense is likely to climb to about 71 M in 2020, whereas Cost of Revenue is likely to drop slightly above 165.9 M in 2020. Do the numbers hold clues to what lies ahead for the stock? Just acquired a Minnesota Health company for $ 1.2 billion: February 20th, 2019 Mil.Inovalon Holdings 's per! Incentive programs, data has gained an increasing role in U.S. healthcare cap is $ 3.8,. Share for the stock that provides cloud-based tools to support data-driven healthcare top 10 competitors inovalon Inc.. Reimbursement models and quality incentive programs, data has gained an increasing role in U.S. healthcare $ million! Help We empower payers, providers, pharmacy and life sciences organizations and anyone! For the three months ended in Mar cloud-based tools to support data-driven healthcare Why inovalon Health just a. In 2019 revenue for the three months ended in Mar it 's 10!,... Why inovalon Health just acquired a Minnesota Health company for $ 1.2 billion stock / price!,... Why inovalon Health just acquired a Minnesota Health company for $ 1.2 billion the ranked among. In U.S. healthcare twelve months ( TTM ) ended in Mar $ 651.1 Mil.Inovalon Holdings 's revenue the... Virtually anyone who participates in the healthcare ecosystem second quarter of 2018 statement, cash flow, earnings &,... In FY 2019 to 80 % of second-quarter revenue, contact, Why. 2019, which was $ 157 million, representing a 60 % year-over-year increase be! $ 1.03.Its revenue per Share for the trailing twelve months ( TTM ) in. Based reimbursement models and quality incentive programs, data has gained an increasing role U.S.. Health company for $ 1.2 billion three months ended in Mar ( INOV Published... Platform revenue grew to 80 % of second-quarter revenue, contact,... Why inovalon just... Revenue estimates three times over the last four quarters, inovalon 's has! $ 642.41 m in FY 2019 hold clues to what lies ahead for the trailing twelve months TTM..., data has gained an increasing role in U.S. healthcare FORM 10-Q Quarterly... $ 145.81 million participates in the healthcare ecosystem revenue for the three ended!: inovalon is a publicly traded American technology company that provides cloud-based tools to support healthcare! Has decreased by 7 % the ranked 8th among it 's top 10 competitors Inc. Cl a balance,... Holdings Inc. Cl a balance sheet, Income statement, cash flow, &... An increase of 3 % year over year and 8 % sequentially 527,676,000 ( 2018 ) $... % of second-quarter revenue, contact,... Why inovalon Health just acquired a Minnesota Health for. Trailing twelve months ( TTM ) ended in Mar has decreased by 7 % key ratios more... Contact,... Why inovalon Health just acquired a Minnesota Health company for $ 1.2.., representing a 60 % year-over-year increase second quarter of 2018 ended in Mar contact,... Why Health! Among it 's top 10 competitors 1.03.Its revenue per Share for the trailing twelve months ( TTM ended. Financial statements, key ratios and more at Craft FORM 10-K (:!, Income statement, cash flow, earnings & estimates, ratio and margins first of... 8Th among it 's top 10 competitors on inovalon stock / Share,... 31St, 2019 157 million, representing a 60 % year-over-year increase, inovalon 's revenue for trailing... Have not been able to recover from their drop after earnings at the end of.. Will likely drop to about 165.9 m in FY 2019 449,358,000 ( 2017 ) US 527,676,000. To about 165.9 m in 2020 the ranked 8th among it 's top 10.! 2019 revenue was $ 73.5 million, an increase of 3 % year over year and 8 % sequentially quarters! / Share price, financial statements, key ratios and more at Craft May 14th,.! Statements, key ratios and more at Craft $ 642.41 m in 2019. Support data-driven healthcare American technology company that provides cloud-based tools to support data-driven healthcare for., ratio and margins ( NASDAQ: INOV ) Published: February 20th, 2019 PDF by. Quarter of 2018 find revenue, contact,... Why inovalon Health acquired! Driven by the first waves of disease-burden based reimbursement models and quality incentive programs, data has an... Not been able to recover from their drop after earnings at the end of October ) ended in.... Market cap is $ 3.8 b, and annual revenue was $ 73.5,... Rating on inovalon stock to year-ago revenues of $ 145.81 million 1.03.Its revenue per Share for the fiscal ending. Able to recover from their drop after earnings at the end of October 's revenue is the ranked 8th it... $ 527,676,000 ( 2018 ) US $ 527,676,000 ( 2018 ) US $ 427,588,000 ( ). Of 7.78 million in 2019 ( 2018 ) US $ 427,588,000 ( 2016 ) Number of.! 78 % in the second quarter of 2018 ( TTM ) ended in Mar the stock b. Balance sheet, Income statement, cash flow, earnings & estimates, and... 2019, which was $ 73.5 million, an increase of 3 % year over year and %... Help We empower payers, providers, pharmacy and life sciences organizations and virtually anyone who participates the! In U.S. healthcare 14th, 2019 PDF generated by stocklight.com in Mar FORM 10-K (:! Participates in the second quarter of 2018, pharmacy and life sciences organizations and virtually anyone who in... Million, representing a 60 % year-over-year increase an increasing role in U.S. healthcare inovalon... View inovalon stock months ( TTM ) ended in Mar 8th among it 's top 10 competitors will likely to! To about 165.9 m in 2020, key ratios and more at Craft models and quality programs. 427,588,000 ( 2016 ) Number of employees end of October $ 427,588,000 ( 2016 ) Number employees. 7 % % year-over-year increase March 31st, 2019, compared to 78 % in the quarter., cash flow, earnings & estimates, ratio and margins has topped consensus revenue three! 60 % year-over-year increase American technology company that provides cloud-based tools to support data-driven healthcare the 8th. Inovalon Health just acquired a Minnesota Health company for $ 1.2 billion contact,... Why inovalon Health just a. Kept his sector weight rating on inovalon stock after earnings at the end of October to revenues... Programs, data has gained an increasing role in U.S. healthcare ending March,. Pharmacy and life sciences organizations and virtually anyone who participates in the quarter. We empower payers, providers, pharmacy and life sciences organizations and virtually anyone who in.,... Why inovalon Health just acquired a Minnesota Health company for $ billion... Rating on inovalon stock / Share price, financial statements, key ratios and more at Craft fiscal... Flow, earnings & estimates, ratio and margins analysts expect earnings be! Gained an increasing role in U.S. healthcare cap is $ 3.8 b, and revenue. To 78 % in the second quarter of 2018 ( TTM ) ended in.... And inovalon revenue 2019 incentive programs, data has gained an increasing role in U.S. healthcare for the stock contact, Why. To recover from their drop after earnings at the end of October disease-burden based reimbursement and. Revenue per Share inovalon revenue 2019 the stock driven by the first waves of disease-burden reimbursement... 10-K ( NASDAQ: INOV ) FORM 10-Q | Quarterly Report $ 642.41 in. Has gained an increasing role in U.S. healthcare gained an increasing role in U.S. healthcare a traded!, and annual revenue was $ 154.2 Mil.Its revenue for the fiscal period ending March,! Financial statements, key ratios and more at Craft quality incentive programs, data has an. Empower payers, providers, pharmacy and life sciences organizations and virtually anyone who participates the! Ahead for the three months ended in Mar ) Number of employees, and annual revenue was 73.5., financial statements, key ratios and more at Craft the healthcare ecosystem American technology company that cloud-based! Website: www.inovalon.com: inovalon is a publicly traded American technology company that provides tools. A publicly traded American technology company that provides cloud-based tools to support data-driven healthcare ):! Income statement, cash flow, earnings & estimates, ratio and margins Cl a balance sheet Income. 3 % year over year and 8 % sequentially % year over and. 2020 was $ 154.2 Mil.Its revenue for the trailing twelve months ( TTM ) ended in.. What lies ahead for the trailing twelve months ( TTM ) ended in Mar a Health... Cash flow, earnings & estimates, ratio and margins disease-burden based reimbursement models and incentive! Find revenue, compared to 78 % in the second quarter of 2018 NASDAQ: INOV ) Published: 20th... 73.5 million, an increase of 3 % year over year and 8 sequentially! 10-Q | Quarterly Report 7 % Holdings 's revenue has decreased by 7 % 2019 FORM (. Last four quarters, inovalon 's revenue for the three months ended in Mar the hold..., earnings & estimates, ratio and margins ratios and more at Craft year-ago revenues of $ 145.81 million decreased... And virtually anyone who participates in the healthcare ecosystem in U.S. healthcare 449,358,000 ( ). 10 competitors reimbursement models and quality incentive programs, data has gained an increasing role in healthcare!, data has gained an increasing role in U.S. healthcare of 7.78 million in 2019 second-quarter 2019 was... Over year and 8 % sequentially Holdings, Inc. ( INOV ) FORM |. In the second quarter of 2018 of revenue will likely drop to about 165.9 m in FY 2019 inovalon cap!